News
Acino receives Frost & Sullivan Award for Enabling ...
acino.swiss
Commenting on Acino strengths and prospects, Frost & Sullivan Senior Research Analyst Aiswariya Chidambaram said: “Its technology expertise and innovation have set it apart in the industry and will allow Acino to further expand on its market share.”
Alexza gets Global Enabling Technology Award from Frost & Sullivan
www.oindpnews.com
Frost & Sullivan Research Analyst Aiswariya Chidambaram commented, “With a single normal breath, the Staccato technology delivers an accurate, rapidly absorbed dose of loxapine through the deep lung. Loxapine, noted for its excellent receptor-binding attributes and positive side-effect profile, is likely to be a preferred antipsychotic of ...
New Hope for Alzheimer's Disease - genengnews.com
www.genengnews.com
Aug 01, · Of those, “More than 100 companies have drugs in the pipeline,” according to Aiswariya Chidambaram, senior research analyst for life sciences, healthcare—Europe, at Frost & Sullivan.
Fast growth forecast for European vaccines market - PharmaTimes
www.pharmatimes.com
The European vaccines market is set to grow by an average of 9.6% each year to 2018, when it will have reached a value of $ billion, according to new...
sorted by relevance / date